Status:
RECRUITING
PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs
Lead Sponsor:
PROCEPT BioRobotics
Conditions:
Benign Prostatic Hyperplasia
Localized Prostate Cancer
Eligibility:
MALE
Up to 80 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to assess the performance and safety of the AQUABEAM Robotic System for the resection and removal of prostate tissue in patients experiencing lower urinary tract sym...
Eligibility Criteria
Inclusion
- International Prostate Symptom Score (IPSS) ≥ 8
- Gleason Grade Group 1-3
- Prostate-specific Antigen (PSA) ≤20ng/mL
- Cancer stage less than or equal to T2c
Exclusion
- Patients with previous surgical treatment of benign prostatic hyperplasia
- MRI evidence of extracapsular extension of cancer
- Any severe illness that would prevent complete study participation or confound study results
Key Trial Info
Start Date :
November 22 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2026
Estimated Enrollment :
125 Patients enrolled
Trial Details
Trial ID
NCT06051942
Start Date
November 22 2022
End Date
May 1 2026
Last Update
August 7 2025
Active Locations (7)
Enter a location and click search to find clinical trials sorted by distance.
1
San Diego Clinical Trials
La Mesa, California, United States, 91942
2
Endeavour Health (NorthShore University HealthSystem)
Glenview, Illinois, United States, 60026
3
Urology Austin, PLLC
Austin, Texas, United States, 78745
4
Potomac Urology Center
Alexandria, Virginia, United States, 22311